InsidersTradesSigma
Track the SIGNAL GENETICS, INC. share price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.3bn. The latest transaction was disclosed on 12 February 2016 (Levée d'options). Among the most active insiders: Riccitelli Samuel D. Every trade is accessible without an account.
Analysts rate SIGNAL GENETICS, INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
SIGNAL GENETICS, INC. 是一家专注于开发遗传疾病诊断解决方案的公司。它在XNAS市场上市。